News

Regeneron's weight-loss drug combo helps preserve muscle in study
Regeneron Pharmaceuticals said on Monday a combination of its experimental drug and Novo Nordisk's obesity drug Wegovy helped ...
New Data Shows Just How Powerful the Next Weight-Loss Drugs May Be
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
Devdiscourse3d
Innovative Weight-Loss Treatments Preserve Muscle Mass: A New Era in Obesity Management
Several pharmaceutical companies are developing novel weight-loss drugs that focus not just on reducing fat but also on ...
Benzinga.com19d
Regeneron's Obesity Trial With Novo Nordisk's Wegovy Hits Lean Target
A Phase 3 trial in obesity in China and a Phase 2b study in ... across Regeneron’s broad pipeline of obesity and metabolic programs focused on improved quality of weight loss, co-morbidities ...
Nasdaq19d
Regeneron Reports Interim Data From Phase 2 COURAGE Study
(RTTNews) - Regeneron Pharmaceuticals ... for the treatment of obesity. COURAGE study was designed to investigate the quality of weight loss in patients with obesity. The treatment is divided ...
PMLive17d
Regeneron gains rights to Hansoh’s GLP-1/GIP receptor agonist in deal worth $2bn
Regeneron Pharmaceuticals has announced that it will be gaining rights to Hansoh Pharmaceuticals’ investigational dual GLP-1/GIP receptor agonist in a deal worth $2bn. The in-licensing agreement will ...
Reuters19d
Regeneron's weight-loss drug helps patients on Wegovy preserve muscle
June 2 (Reuters) - Regeneron (REGN.O), opens new ... the highest rate among all groups tested in the study. "Incremental improved weight loss from double and triple therapy are promising," said ...